At least six companies have emerged to help unstick what developers say is a “bottleneck” in advancing complex genetic treatments. Editor’s note: BioPharma Dive, as part of Emerging Biotech Weekly, is taking a closer look at competitive areas of startup activity. We aim
Cell and gene therapy manufacturing: the next generation of startups
